Is Alterity Therapeutics Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Alterity Therapeutics Ltd (ATH.AX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Alterity Therapeutics Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Alterity Therapeutics Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Alterity Therapeutics Ltd?

Muslim investors may consider investing in Alterity Therapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Alterity Therapeutics Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Alterity Therapeutics Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Alterity Therapeutics Ltd updated?

The Shariah compliance status of Alterity Therapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Alterity Therapeutics Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Alterity Therapeutics Ltd?

You can check the latest Shariah compliance status of Alterity Therapeutics Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ATH.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 19, 2026

Report Source: 2026 2nd Quarter Report

Analyst's Ratings for Alterity Therapeutics Ltd (ATH.AX)

Based on 5 analysts giving stock ratings to Alterity Therapeutics Ltd in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Alterity Therapeutics Ltd. Stock Analysis ATH.AX

Australia Health Care Micro Cap Report: Q2, 2026

Alterity Therapeutics Ltd. is a clinical stage biotechnology company. The company is headquartered in Melbourne, Victoria and currently employs 9 full-time employees. The company went IPO on 2000-03-28. The firm is focused on developing disease modifying treatments for neurodegenerative diseases. The firm's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The company has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The firm also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. Its lead asset, ATH434, is in a randomized, double blind, placebo-controlled Phase II clinical trial in participants with MSA. The firm is also conducting various nonclinical studies with ATH434 for use in Parkinson’s disease based on imaging of brain iron, preservation of neurons, and improvements in motor performance.

Key Statistics of Alterity Therapeutics Ltd (ATH.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.01AUD0.01

Today's Open

AUD0.01

Volume

26.29M

P/E Ratio (TTM)

52 Week Range

AUD0.01AUD0.02

Market Cap

108.75M

Avg. Volume

4.42M

Dividend Yield

Financial Metrics & Statements of Alterity Therapeutics Ltd (ATH.AX)

FAQ's for Alterity Therapeutics Ltd (ATH.AX)

According to Musaffa’s Shariah screening methodology, Alterity Therapeutics Ltd (ATH.AX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.